Back to Journals » Drug Design, Development and Therapy » Volume 9

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance

Total article views   Abstract views HTML views PDF downloads Totals
7,687 Dovepress* 5,567 1,061+ 1,511 6,628
PubMed Central* 0 1,059 358 1,059
Totals 5,567 2,120 1,869 7,687
*Since 2 June 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar